WestVac BioPharma Co., Ltd. is an innovative biopharmaceutical enterprise integrating vaccine R&D, production and sales, including WestVac Biopharma located in Beijing and Chengdu and WestVac Biopharma (Guangzhou), a wholly-owned subsidiary company of WestVac Biopharma.Our investment shareholders include CICC Capital, Qingdao Haier, Shanghai Pharmaceuticals Holding, Sichuan Development Holding, China Taiping, Sichuan West China Health, CDH Investments and others. The company has been successfully selected into the list of unicorn companies for five consecutive years from 2021 to 2025. WestVac is currently undergoing Series D financing.
In terms of production, quality, operations management and other areas, WestVac Biopharma has introduced top talents from well-known Chinese and international vaccine companies. It has also established a complete production and quality management system to ensure a smooth mass production of vaccines.
With five major technology platforms, the company has developed over 20 product pipelines including COVID-19 vaccines and their upgraded versions (recombinant trivalent XBB COVID-19 vaccine and recombinant monovalent XBB COVID-19 vaccine), recombinant trivalent influenza vaccine, recombinant COVID-19-influenza combined vaccine, nasal spray respiratory syncytial virus (RSV) vaccine, acne vaccine, bacterial vaccines, anti-fibrotic vaccine, and novel therapeutic cancer vaccines.
WestVac Biopharma Co., Ltd.
WestVac Biopharma Co., Ltd. is located in in Chengdu Tianfu International Biological City. It has completed construction of 5,000-litre and 3,000-litre insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses. The GMP production lines were well established with the “Drug Production License" in place in September, 2021. WestVac Biopharma has received the GMP (Good Manufacturing Practice) certificate from the Federal Commission for Protection against Sanitary Risks (COFEPRIS) in Mexico in January, 2024, a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S). This certification covers all the COVID-19 vaccines produced by WestVac Biopharma using insect cells (Sf9), including the Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 Cell) and other COVID-19 vaccine series. The Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 Cell) and the Recombinant COVID-19 (XBB.1.5) Protein Vaccine (Sf9 Cell) were honored as one of the "Top Ten Advances in China's Biomedical Technology 2023" by the China Medicinal Biotech Association and the journal of Chinese Medicinal Biotechnology in January 2024.
WestVac Biopharma (Guangzhou) Co., Ltd.
WestVac Biopharma (Guangzhou) is located in Guangzhou Economic Development Zone. It has completed scale-up construction of insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses, and obtained the “Drug Production License" in February, 2024.
WestVac Biopharma (Beijing) Co., Ltd.
WestVac Biopharma (Beijing) Co., Ltd. is located in Beijing Daxing Biomedical Industry Base. It is a high-tech enterprise specializing in biopharmaceutical R&D and industrialization. Leveraging the strong scientific team from West China and advanced technology platforms, the company focuses on biopharmaceutical research, production and industrialization. By integrating domestic and international resources, WestVac Biopharma (Beijing) provides end-to-end services from early-stage R&D to clinical translation, while actively promoting industry-academia-research collaboration to accelerate the commercialization of biotechnological achievements.
WestVac Biopharma has established a sound communication mechanism with many international organizations such as the World Health Organization (WHO), Bill & Melinda Gates Foundation, PATH, The Coalition for Epidemic Preparedness Innovations (CEPI), and European Vaccine Initiative (EVI). In the future, WestVac Biopharma will grow into a world leading vaccine and immunotherapy platform in line with its corporate philosophy of "We Initiate Science & Technology Value, Always for Caring". Westvac extensively explores and innovates to prevent and fight human diseases. Westvac brings innovative vaccines and immunotherapies from China to the world for the benefit of mankind.
